DCT

2:25-cv-02254

Merck Sharp & Dohme BV v. Xiromed Pharma Espaa SL

General
Filed
04/02/25
Cause of ActionPatent Infringement
SectorBiotech
StatusOpen
Patent Owner
Operating Company
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
--
74%